{"id":"NCT03888755","sponsor":"Shire","briefTitle":"A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants","officialTitle":"An Open-Label Study of Icatibant in Japanese Subjects With Acute Attacks of Hereditary Angioedema.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03-18","primaryCompletion":"2016-02-12","completion":"2016-02-12","firstPosted":"2019-03-25","resultsPosted":"2019-08-08","lastUpdate":"2021-06-03"},"enrollment":8,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hereditary Angioedema (HAE)"],"interventions":[{"type":"DRUG","name":"Icatibant","otherNames":[]}],"arms":[{"label":"Icatibant","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to evaluate the efficacy, pharmacokinetics (PK), and safety of icatibant for the treatment of acute attacks in Japanese participants with type I or type II hereditary angioedema (HAE).","primaryOutcome":{"measure":"Time to Onset of Symptom Relief (TOSR)","timeFrame":"Baseline up to 120 hours post-treatment","effectByArm":[{"arm":"Icatibant","deltaMin":1.75,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":8,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":8},"commonTop":["HEREDITARY ANGIOEDEMA","HEADACHE"]}}